28159 AVENUE STANFORD, VALENCIA, CA
Announces CEO Transition
Unregistered Sales of Equity Securities
Successfully Completes Australian Equity Raise
Reports Second Quarter 2025 Financial Results, Updates Full-Year Guidance, and Highlights Continued Clinical Innovation
Changes in Board, Management or Compensation
Material disclosure
Amendments to Articles of Incorporation or Bylaws
Reports First Quarter 2025 Financial Results
Q2
Q1
FY 2023
Q3
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Prospectus Filed Pursuant to Rule 424(b)(2)
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Correspondence
Submission Upload